Magnus Winterman
Head of Investor Relations at InsuLife | Stockholm County, Sweden
Magnus Winterman’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Founder & Owner at WIN CONSULTING in April 2013 - Present
Head of Investor Relations at InsuLife in October 2025 - Present
Group CEO at Syncro Group AB (publ) in January 2022 - October 2022
InsuLife is a Norwegian company aiming at developing and bringing the unparalleled investigational ILS-2501 apply-on-the-skin based insulin to market. This includes the carrying out of any and all necessary product studies and authorization activities. ILS-2501 will represent an international innovation and paradigm shift. Insulin in apply-on-the-skin form has the potential to fulfill a need for people with diabetes who want to avoid needles and to take insulin in the most practical way. There is no transdermal apply-on-the-skin insulin in the global pharmaceutical market today. InsuLife are developing a novel product with delivery of apply-on-the-skin insulin which will be easy form of administration and efficacy is expected to be comparable to the traditional subcutaneous injections. The Future of Insulin Delivery ILS-2501 aims to be the first transdermal apply-on-the-skin Insulin. Applied directly onto the skin, ILS-2501 eliminates the use of needles. The target of this breakthrough product: Eliminates multiple injections per day Potential for better patient compliance Utilizes unmodified human insulin, a “commodity” drug product enabling cost competitiveness Shows strong indication of stability in room temperature, - no need for refrigeration
Discover more about InsuLifeConsultant on Intellectual Property Matters; Retired June 15 2018 as Chief IP Counsel, Pfizer
Member, Board of Directors at Starton Therapeutics
(May 2019 – Present)
Dedicated Sales Professional | Expert in Building New Partner Relationships & Driving Revenue Growth | Extensive Network | Business Development
Ambassador for InsuLife – Sweden
Driven by a highly skilled and passionate team from across the pharmaceutical and life sciences industries, InsuLife is creating a groundbreaking solution that could transform the future of diabetes care. As a fast-growing MedTech company ba...
Co-founder and Chief Executive Officer at InsuLife AS
I offer mentoring and Strategic advise to executives in the Pharmaceutical industry.
International Business Developer / Executive Consultant
International Business Development at Own
(Mar 2008 – Present)
Clinical, Marketing and Business Development
VP Medical Department at Medistim ASA
(Mar 2016 – Present)
CFO at Insulife
InsuLife is a Norwegian company aiming at developing and bringing the unparalleled investigational INS-2301 spray-based insulin to market. This includes the carrying out of all necessary product studies and authorization activities.
INS-2301 will represent an international i...
What is Magnus Winterman email address?
Email Magnus Winterman at [email protected] and [email protected]. This email is the most updated Magnus Winterman's email found in 2026.
How to contact Magnus Winterman?
To contact Magnus Winterman send an email to [email protected] or [email protected]. (updated on November 29, 2025)
What company does Magnus Winterman work for?
Magnus Winterman works for InsuLife.
What is Magnus Winterman's role at InsuLife?
Magnus Winterman is Head of Investor Relations
What industry does Magnus Winterman work in?
Magnus Winterman works in the Human Resources industry.